Masayuki Yokoyama

Prof. Masayuki Yokoyama


Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2010 in Expert Opinion on Drug Delivery
Verified
Journal Article
Closed access
MYMasayuki Yokoyama
Masayuki Yokoyama
Importance of the field: A polymeric micelle is a macromolecular assembly composed of an inner core and an outer shell, and most typically is formed from block copolymers. In the last two decades, polymeric micelles have been actively studied as a new type of drug carrier system, in particular for drug targeting of anticancer drugs to solid tumors.Areas covered in this review: In this review, polymeric micelle drug carrier systems are discussed with a focus on toxicities of the polymeric micelle carrier systems and on pharmacological activities of the block copolymers. In the first section, the importance of the above-mentioned evaluation of these properties is explained, as this importance does not seem to be well recognized compared with the importance of targeting and enhanced pharmacological activity of drugs, particularly in the basic studies. Then, designs, types and classifications of the polymeric micelle system are briefly summarized and explained, followed by a detailed discussion regarding seve...

8 March 2019 in Science and Technology of Advanced Materials
Verified
Journal Article
Open access
KSKouichi Shiraishi
Kouichi Shiraishi
MYMasayuki Yokoyama
Masayuki Yokoyama
Polymeric-micelle carrier systems have emerged as a novel drug-carrier system and have been actively studied for anticancer drug targeting. In contrast, toxicological and immunological concerns related to not only polymeric-micelle carrier systems, but also other nanocarrier systems, have received little attention owing to researchers’ focus on therapeutic effects. However, in recent clinical contexts, biopharmaceuticals’ effects on immune responses have come to light, requiring that researchers substantively explore the potential negative side effects of nanocarrier systems and of therapeutic proteins in order to develop nanocarrier systems suitable for clinical use. The present review describes current insights into both toxicological and immunological issues regarding polymeric-micelle carrier systems. The review focuses on immunogenicity issues of polymeric-micelle carrier systems possessing poly(ethylene glycol) (PEG). We conclude that PEG-related immunogenicity is deeply related to characteristics of a counterpart block of PEG-conjugates, and we propose future directions for addressing this unresolved issue. Graphical abstract

1 July 2016 in Journal of Controlled Release
Verified
Journal Article
Closed access
KSKouichi Shiraishi
Kouichi Shiraishi
KKKumi Kawano
Kumi Kawano
YMYoshie Maitani
Yoshie Maitani
TATaiki Aoshi
Taiki Aoshi
KIKen Ishii
Ken Ishii
MYMasayuki Yokoyama
Masayuki Yokoyama

1 May 2017 in Journal of Controlled Release
Verified
Journal Article
Closed access
KSKouichi Shiraishi
Kouichi Shiraishi
ZWZuojun Wang
Zuojun Wang
DKDaisuke Kokuryo
Daisuke Kokuryo
IAIchio Aoki
Ichio Aoki
MYMasayuki Yokoyama
Masayuki Yokoyama

1 April 2015 in Journal of Controlled Release
Verified
Journal Article
Closed access
KSKouichi Shiraishi
Kouichi Shiraishi
YSYusuke Sanada
Yusuke Sanada
SMShinichi Mochizuki
Shinichi Mochizuki
KKKumi Kawano
Kumi Kawano
YMYoshie Maitani
Yoshie Maitani
MYMasayuki Yokoyama
Masayuki Yokoyama

1 November 2023 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
SOSatoshi Okada
Satoshi Okada
KNKai Nishimura
Kai Nishimura
QAQarri Ainaya
Qarri Ainaya
KSKouichi Shiraishi
Kouichi Shiraishi
SASergey A. Anufriev
Sergey A. Anufriev
HNHiroyuki Nakamura
Hiroyuki Nakamura